The Liu lab is interested in the molecular mechanisms of how morphologic patterns of cytoplasmic antimicrobial granules are affected by genetics and environmental triggers, and their clinical relevance.
The Faith lab is developing and applying experimental and computational tools to understand gut microbiota structure and function to develop live defined microbial therapeutics.
Dr. Lee studies dietary therapy and the role of food additives in IBD with the goal of helping children achieve their potential and not be limited by their medical conditions.
The Martens lab investigates the symbiotic microorganisms in the human gastrointestinal tract at multiple levels with the goal of using diet and gut microbial interventions to treat chronic conditions such as Inflammatory Bowel Disease.
